Comparison of clinical pharmacy specialists and primary care physicians in treatment of type 2 diabetes mellitus in rural Veterans Affairs facilities

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Katelyn WassellJeffrey Zuber

Abstract

Results of a study to compare the impact of clinical pharmacy specialist (CPS) interventions with primary care physician (PCP) interventions in veterans with type 2 diabetes mellitus (T2D) in a rural setting are presented. A retrospective analysis was performed examining veterans diagnosed with T2D with a glycosylated hemoglobin (HbA1c) of ≥8% receiving treatment at a rural community-based outpatient clinic associated with the Memphis Veterans Affairs Medical Center. Propensity score matching was used to create a 1:1 cohort of patients managed by physicians or clinical pharmacy specialists. Patients were evaluated as their own control and as compared cohorts. The primary outcome was the difference in HbA1c. Secondary outcomes included changes in total cholesterol, low-density lipoprotein cholesterol, triglycerides, and body mass index. Data were collected from 124 patients (n = 62 CPS patients, n = 62 PCP patients). Baseline HbA1c in the CPS and PCP groups were 10.2% ± 1.9% and 9.6% ± 1.6%, respectively. Postintervention HbA1c in the CPS cohort was 7.5% ± 1.1% (range, 6-11.7%), indicating an absolute reduction of 2.7% (p < 0.001). Postintervention HbA1c in the PCP cohort was 8.5% ± 1.5% (range, 5.4-12.6%), resulting in an absol...Continue Reading

References

Oct 28, 2003·Diabetes Care·David M Eddy, Leonard Schlessinger
Sep 10, 2010·Journal of Vascular Surgery·Vickie R DriverGary Gibbons
Nov 15, 2011·Diabetes Research and Clinical Practice·David R WhitingJonathan Shaw
Dec 25, 2012·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Julie M SeaseKatherine R Gerrald
Mar 8, 2013·Diabetes Care·UNKNOWN American Diabetes Association
May 4, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Eric J IpDeempal C Bhatt
Jul 4, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Joanna LeśniowskaMarta Fedyna
Jan 13, 2015·Health Care Management Science·Kathleen Carey, Theodore Stefos
Jan 28, 2015·Journal of Rehabilitation Research and Development·Heather FranklinMd Mph
Mar 26, 2016·Journal of Managed Care & Specialty Pharmacy·John J KoPaul J Godley
Jan 11, 2017·Journal of Diabetes·Payal H MaratheKelly L Close

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.